Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Gencia Looks To Improve Steroids With Takeda Deal

This article was originally published in PharmAsia News

Executive Summary

With its first collaboration on the books, Gencia CEO Allen Cunningham says the biotech is putting all its focus into developing those compounds and will look to ink further collaborations at a later date.



Related Companies